EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Surgery Partners, Inc. (SGRY) had EBITDA of $103.80M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$776.00M
Net Income	$-37.70M
Cost of Goods Sold	$614.10M
Gross Profit	$161.90M
Operating Expenses	$714.10M
Operating Income	$61.90M
Non-Operating Income/Expense	$-62.20M
Pre-Tax Income	$-0.30M
Normalized Pre-Tax Income	$-0.30M
Income after Taxes	$-0.30M
Income from Continuous Operations	$-0.30M
Consolidated Net Income/Loss	$-0.30M
Normalized Income after Taxes	$-0.30M
EBIT	$67.50M
EBITDA	$103.80M
Weighted-Average Shares Outstanding (Basic)	126.60M
Weighted-Average Shares Outstanding (Diluted)	126.60M
Earnings per Share (EPS) (Basic)	$-0.30
Earnings per Share (EPS) (Diluted)	$-0.30
Balance Sheet Financials
Current Assets	$1.07B
Property, Plant, and Equipment	$1.15B
Long-Term Assets	$6.87B
Total Assets	$7.95B
Current Liabilities	$569.40M
Long-Term Debt	$3.45B
Long-Term Liabilities	$4.22B
Total Liabilities	$4.79B
Common Equity	$3.16B
Tangible Shareholders Equity	$-2.02B
Shareholders Equity	$3.16B
Common Shares Outstanding	128.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.00M
Cash Flow from Investing Activities	$-76.40M
Cash Flow from Financial Activities	$30.20M
Beginning Cash	$269.50M
End Cash	$229.30M
Increase/Decrease in Cash	$-40.20M
Stock-Based Compensation	$7.60M
Common Stock Dividends Paid	$-62.30M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.13
Gross Margin	20.86%
Operating Margin	7.98%
EBIT Margin	8.70%
EBITDA Margin	--
Pre-Tax Profit Margin	-0.04%
Profit Margin	-4.86%
Free Cash Flow	$-11.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	6.97
Receiveable Turnover	1.36
Days Sales in Receivables	66.18
Return on Equity	-0.01%
Return on Tangible Equity	0.01%
Return on Assets	-0.00%
Return on Investments	-0.00%
Book Value Per Share	$24.62
Free Cash Flow per Share	$-0.09
Operating Cash Flow per Share	$0.05

Data from Zacks Investment Research, Inc.